The Gross Margin of Innovent Biologics Inc (1801.HK) is 85.60%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 85.60% |
| 2023-12-31 | 81.69% |
| 2022-12-31 | 79.57% |
| 2021-12-31 | 88.16% |
| 2020-12-31 | 89.91% |
| 2019-12-31 | 88.08% |
| 2018-12-31 | 88.08% |